Elevated parathyroid hormone 44-68 in idiopathic calcium pyrophosphate dihydrate crystal deposition disease. Role of menopause and iron metabolism?

Journal of Rheumatology

Volumn 35, Issue 2, 2008, Pages 315-318

  Pawlotsky, Yves ^a,b,e   Massart, Catherine ^a,c   Guggenbuhl, Pascal ^a,d   Albert, Jean David ^a,b   Perdriger, Aleth ^a,b   Meadeb, Jean ^a,b   Chalès, Gérard ^a,d  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b Department of Rheumatology ^*

^c Laboratory of Molecular Genetics and Hormonology

^d INSERM   (France)

^e SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Idiopathic CPPD crystal deposition disease; Iron metabolism; Menopause; Parathyroid hormone 44 68

Indexed keywords

CALCIUM; CALCIUM PYROPHOSPHATE; FERRITIN; IRON; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGE DISTRIBUTION; AGED; ARTHROPATHY; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; HEMOCHROMATOSIS; HORMONE METABOLISM; HUMAN; IDIOPATHIC CALCIUM PYROPHOSPHATE DIHYDRATE CRYSTAL DEPOSITION DISEASE; IRON METABOLISM; MALE; MENOPAUSE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SEX RATIO;

ADULT; AGED; CASE-CONTROL STUDIES; CHONDROCALCINOSIS; FEMALE; FERRITINS; HUMANS; IRON; MALE; MIDDLE AGED; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; POSTMENOPAUSE;

EID: 39549102005     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Phelps P, Hawker CD. Serum parathyroid hormone level in patients with calcium pyrophosphate crystal deposition disease (chondrocalcinosis, pseudogout). Arthritis Rheum 1973;16:590-6.
2. McCarthy DJ, Silcox DC, Coe F, et al. Diseases associated with calcium pyrophosphate dihydrate crystal deposition. A controlled study. Am J Med 1974;56:704-14.
3. Pawlotsky Y, Catheline M, Delbary M, et al. Hyperparathormonémie normocalcémtque et chondrocalcinose articulaire: étude de 69 patients comparés à 57 sujets témoins. Rev Rhum 1981;48:799-806.
4. Pawlotsky Y, Catheline M, Jean S, et al. Arthropathies métaboliques calciques avec hyperparathormonémie 44-68 normocalcémique en dehors de l'hémochromatose géné tique [abstract]. Rev Rhum 1994:61:695.
5. Pawlotsky Y, Le Dantec P, Moirand R, et al. Elevated parathyroid hormone 44-68 and osteoarticular changes in patients with genetic hemochromatosis. Arthritis Rheum 1999;42:799-806.
6. Ryan ML, McCarthy DJ. Calcium pyrophosphate crystal deposition disease; Pseudogout; Articular Chondrocalcinosis. In: McCarthy DJ, Koopman WJ, editors. Arthritis and allied conditions. Philadelphia: Lea and Febiger; 1993:1835-55.
7. Doherty M. Crystal-related arthropathies. Calcium pyrophosphate dihydrate. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby; 2000;8.16:1-12.
8. EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000;33:485-504.
9. Somjen D, Binderman I, Schlüter KD, Wingender E, Mayer H, Kayes AM. Stimulation by defined parathyroid hormone fragments of cell proliferation in skeletal-derived cell cultures. Biochem J 1990;272:781-5.
10. Silbermann M, Shurtz-Swirski R, Lewinson D, Schenzer P, Mayer H. In vitro response of neonatal condylar cartilage to simultaneous exposure to the parathyroid fragments 1-34, 28-48, and 53-84. Calcif Tissue Int 1991;48:250-66.
11. Milman N. Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy. Int J Hematol 1996;63:103-35.
12. Smans KA, D'Haese PC, Van Landeghem GF, et al. Transferrin-mediated uptake of aluminium by human parathyroid cells results in reduced parathyroid hormone secretion. Nephrol Dial Transplant 2000;15:1328-36.